Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
LendingStandard closes $6.7M round with Flyover Capital among key longterm investors
A Kansas City startup’s efforts to streamline the commercial real estate industry are not only reducing wasted time and frustration for lenders and borrowers, said Keith Molzer, it’s making good on investors’ expectations of the tech-driven Saas marketplace. “LendingStandard has listened and responded to what the market needs,” said Molzer, founding managing partner at Flyover…
The journey can make or break an entrepreneur; Pipeline gala returns June 15 to celebrate connectivity at the intersection
Editor’s note: Pipeline Entrepreneurs is a partner of Startland News, though this report was produced independently by the nonprofit newsroom. Pipeline Entrepreneurs’ new era is all about community, said Melissa Vincent, with more than a nod to the resilience needed to sustain a vibrant startup ecosystem. “When you go through the Pipeline program, it becomes…
Royals partner with KC-linked CBD brand to tout health benefits of hemp for athletes
As an entrepreneur who grew up in Kansas City, teaming up with the Kansas City Royals to promote high-quality CBD products is a dream come true, said Dan Huerter, CEO of Pure Spectrum CBD. “To be able to work with such an iconic organization and to be a part of promoting health and wellness in…
Yoli Tortilleria’s grind to “honor the very humble tortilla” earns James Beard Award
Editor’s note: The following story was originally published by KCUR, Kansas City’s NPR member station, and a fellow member of the KC Media Collective. Click here to read the original story or here to sign up for KCUR’s email newsletter. Yoli Tortilleria, a Mexican tortilla bakery with a retail store on Jefferson Street on Kansas City’s Westside and a manufacturing location…